医学
肝病
临床试验
发病机制
疾病
生物信息学
病理
内科学
生物
作者
Reiner Wiest,Agustı́n Albillos,Michael Trauner,Jasmohan S. Bajaj,Rajiv Jalan
标识
DOI:10.1016/j.jhep.2017.05.007
摘要
Summary
The gut-liver axis is widely implicated in the pathogenesis of liver diseases, where it is increasingly the focus of clinical research. Recent studies trialling an array of therapeutic and preventative strategies have yielded promising results. Considering these strategies, the armamentarium for targeting the gut-liver axis will continue to expand. Further clinical trials, translated from our current knowledge of the gut-liver axis, promise an exciting future in liver treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI